We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
18 hedge funds and large institutions have $48M invested in ADMA Biologics in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
72.71% more ownership
Funds ownership: 0% → 72.71% (+73%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 19 → 18 (-1)
31% less capital invested
Capital invested by funds: $69.7M → $48M (-$21.8M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
–
Increased
4
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
IHM
Iguana Healthcare Management
New York
|
-$1.15M |
| 2 |
SIM
Spark Investment Management
New York
|
-$147K |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$97.6K |
| 4 |
PA
Perceptive Advisors
New York
|
-$78.6K |
| 5 |
TI
Telemetry Investments
New York
|
-$72K |
